These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 16268466

  • 21. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party.
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [Abstract] [Full Text] [Related]

  • 22. Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).
    Halperin JL, Executive Steering Committee, SPORTIF III and V Study Investigators.
    Am Heart J; 2003 Sep; 146(3):431-8. PubMed ID: 12947359
    [Abstract] [Full Text] [Related]

  • 23. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
    Lip GY, Frison L, Halperin JL, Lane DA.
    J Am Coll Cardiol; 2011 Jan 11; 57(2):173-80. PubMed ID: 21111555
    [Abstract] [Full Text] [Related]

  • 24. Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.
    Colwell CW, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.
    J Thromb Haemost; 2003 Oct 11; 1(10):2119-30. PubMed ID: 14521593
    [Abstract] [Full Text] [Related]

  • 25. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
    Linnemann B, Zgouras D, Schindewolf M, Schwonberg J, Jarosch-Preusche M, Lindhoff-Last E.
    Blood Coagul Fibrinolysis; 2008 Mar 11; 19(2):159-65. PubMed ID: 18277138
    [Abstract] [Full Text] [Related]

  • 26. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J, Nieto JA, Tiberio G, Piccioli A, Di Micco P, Prandoni P, Monreal M, RIETE Registry.
    Thromb Haemost; 2008 Sep 11; 100(3):435-9. PubMed ID: 18766259
    [Abstract] [Full Text] [Related]

  • 27. Ximelagatran, a new oral direct thrombin inhibitor, for the prevention of venous thromboembolic events in major elective orthopaedic surgery. Efficacy, safety and anaesthetic considerations.
    Rosencher N.
    Anaesthesia; 2004 Aug 11; 59(8):803-10. PubMed ID: 15270973
    [Abstract] [Full Text] [Related]

  • 28. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
    Blanco-Molina A, Trujillo-Santos J, Criado J, Lopez L, Lecumberri R, Gutierrez R, Monreal M, RIETE Investigators.
    Thromb Haemost; 2007 Feb 11; 97(2):186-90. PubMed ID: 17264945
    [Abstract] [Full Text] [Related]

  • 29. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.
    Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW.
    Ann Intern Med; 2002 Oct 15; 137(8):648-55. PubMed ID: 12379064
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.
    Kucher N, Leizorovicz A, Vaitkus PT, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ.
    Arch Intern Med; 2005 Feb 14; 165(3):341-5. PubMed ID: 15710801
    [Abstract] [Full Text] [Related]

  • 31. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
    Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE.
    Circulation; 2007 Sep 25; 116(13):1497-503. PubMed ID: 17846285
    [Abstract] [Full Text] [Related]

  • 32. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, Prandoni P, Brighton TA, INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism).
    Circulation; 2014 Sep 23; 130(13):1062-71. PubMed ID: 25156992
    [Abstract] [Full Text] [Related]

  • 33. Venous thromboembolism: risk factors for recurrence.
    Zhu T, Martinez I, Emmerich J.
    Arterioscler Thromb Vasc Biol; 2009 Mar 23; 29(3):298-310. PubMed ID: 19228602
    [Abstract] [Full Text] [Related]

  • 34. Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran.
    Agnelli G, Eriksson BI, Cohen AT, Bergqvist D, Dahl OE, Lassen MR, Mouret P, Rosencher N, Andersson M, Bylock A, Jensen E, Boberg B, EXTEND Study Group.
    Thromb Res; 2009 Mar 23; 123(3):488-97. PubMed ID: 18485453
    [Abstract] [Full Text] [Related]

  • 35. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug 23; 14(78):127-32. PubMed ID: 16106594
    [Abstract] [Full Text] [Related]

  • 36. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.
    Eriksson BI, Agnelli G, Cohen AT, Dahl OE, Mouret P, Rosencher N, Eskilson C, Nylander I, Frison L, Ogren M, METHRO III Study Group.
    Thromb Haemost; 2003 Feb 23; 89(2):288-96. PubMed ID: 12574809
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ximelagatran.
    Choudhury A, Goyal D, Lip GY.
    Drugs Today (Barc); 2006 Jan 23; 42(1):3-19. PubMed ID: 16511607
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov 23; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.